SI3380554T2 - Kristalne oblike per-kloro-gama-ciklodekstrinov - Google Patents

Kristalne oblike per-kloro-gama-ciklodekstrinov

Info

Publication number
SI3380554T2
SI3380554T2 SI201630867T SI201630867T SI3380554T2 SI 3380554 T2 SI3380554 T2 SI 3380554T2 SI 201630867 T SI201630867 T SI 201630867T SI 201630867 T SI201630867 T SI 201630867T SI 3380554 T2 SI3380554 T2 SI 3380554T2
Authority
SI
Slovenia
Prior art keywords
cyclodextrines
chloro
gamma
per
crystalline forms
Prior art date
Application number
SI201630867T
Other languages
English (en)
Other versions
SI3380554T1 (sl
Inventor
Walter Cabri
Antonio Ricci
Jacopo Zanon
Saswata Lahiri
Govind Singh
Shivaji Haribhau Shelke
Shridhar Reddy
Nitin Kumar
Madan Singh
Original Assignee
Fresenius Kabi Ipsum S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57714631&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3380554(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi Ipsum S.R.L. filed Critical Fresenius Kabi Ipsum S.R.L.
Publication of SI3380554T1 publication Critical patent/SI3380554T1/sl
Publication of SI3380554T2 publication Critical patent/SI3380554T2/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
SI201630867T 2015-11-25 2016-11-24 Kristalne oblike per-kloro-gama-ciklodekstrinov SI3380554T2 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3842DE2015 2015-11-25
EP16822270.1A EP3380554B2 (en) 2015-11-25 2016-11-24 Crystalline forms of per-chloro-gamma-cyclodextrines
PCT/IB2016/057088 WO2017089978A1 (en) 2015-11-25 2016-11-24 Crystalline forms of per-chloro-gamma-cyclodextrines

Publications (2)

Publication Number Publication Date
SI3380554T1 SI3380554T1 (sl) 2020-10-30
SI3380554T2 true SI3380554T2 (sl) 2024-01-31

Family

ID=57714631

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201630867T SI3380554T2 (sl) 2015-11-25 2016-11-24 Kristalne oblike per-kloro-gama-ciklodekstrinov

Country Status (8)

Country Link
US (1) US10414830B2 (sl)
EP (2) EP3380554B2 (sl)
KR (1) KR102251683B1 (sl)
CN (1) CN108291057B (sl)
AU (1) AU2016359431B2 (sl)
ES (1) ES2812226T5 (sl)
SI (1) SI3380554T2 (sl)
WO (1) WO2017089978A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10414829B2 (en) 2015-11-25 2019-09-17 Fresenius Kabi Ipsum S.R.L. Process for the preparation of sugammadex and its intermediates
WO2017089978A1 (en) 2015-11-25 2017-06-01 Fresenius Kabi Antiinfectives S.R.L. Crystalline forms of per-chloro-gamma-cyclodextrines
KR20180127428A (ko) 2016-03-22 2018-11-28 프레제니우스 카비 입섬 에스. 알. 엘. 슈가마덱스의 제조를 위한 개선된 방법
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
KR20210087934A (ko) * 2018-09-27 2021-07-13 베르텐스타인 바이오파마 게엠베하 슈가마덱스의 신규한 결정질 형태
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
US11097023B1 (en) 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex
CN113637097A (zh) * 2021-08-10 2021-11-12 北京恒创星远医药科技有限公司 6-全脱氧-6-全碘代-γ-环糊精晶体及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242015B (en) * 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
CN101864003B (zh) 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
WO2012025937A1 (en) 2010-08-25 2012-03-01 Ramamohan Rao Davuluri Improved process for preparation of sugammadex
JP6249208B2 (ja) 2012-10-31 2017-12-20 国立大学法人 名古屋工業大学 糖誘導体及びそれを用いた抗菌剤
US9879096B2 (en) 2013-02-14 2018-01-30 Neuland Laboratories Limited Process for preparation of sugammadex sodium
CN105273095A (zh) 2014-05-28 2016-01-27 四川海思科制药有限公司 一种舒更葡糖钠及其中间体的制备方法
CN104628891B (zh) * 2015-01-20 2017-05-03 中国大冢制药有限公司 一种6‑脱氧‑6‑卤代环糊精的制备方法
CN104844732B (zh) 2015-03-27 2017-05-03 山东滨州智源生物科技有限公司 一种舒更葡糖钠的制备方法
CN107849157A (zh) 2015-05-29 2018-03-27 拉克什米·普拉萨德·阿拉帕斯 制备舒更葡糖及其中间体的方法
US10414829B2 (en) 2015-11-25 2019-09-17 Fresenius Kabi Ipsum S.R.L. Process for the preparation of sugammadex and its intermediates
WO2017089978A1 (en) 2015-11-25 2017-06-01 Fresenius Kabi Antiinfectives S.R.L. Crystalline forms of per-chloro-gamma-cyclodextrines
KR20180127428A (ko) 2016-03-22 2018-11-28 프레제니우스 카비 입섬 에스. 알. 엘. 슈가마덱스의 제조를 위한 개선된 방법

Also Published As

Publication number Publication date
EP3380554B2 (en) 2023-10-18
SI3380554T1 (sl) 2020-10-30
EP3380554A1 (en) 2018-10-03
WO2017089978A1 (en) 2017-06-01
EP3380554B1 (en) 2020-06-10
AU2016359431A1 (en) 2018-05-31
ES2812226T5 (es) 2024-04-29
CN108291057B (zh) 2021-07-13
AU2016359431B2 (en) 2020-10-22
US10414830B2 (en) 2019-09-17
KR102251683B1 (ko) 2021-05-13
EP3741801A1 (en) 2020-11-25
CN108291057A (zh) 2018-07-17
KR20180102072A (ko) 2018-09-14
US20180346608A1 (en) 2018-12-06
ES2812226T3 (es) 2021-03-16

Similar Documents

Publication Publication Date Title
HK1252845A1 (zh) 勞拉替尼游離碱的結晶形式
EP3136857A4 (en) Crystalline form of baricitinib
IL257026A (en) Solid state forms of eluxadoline
IL246385A0 (en) Crystalline forms of efitinib di-malate
SI3380554T1 (sl) Kristalne oblike per-kloro-gama-ciklodekstrinov
HK1244274A1 (zh) C21h22ci2n4o2的晶型
HK1255112A1 (zh) 吉西他濱的晶型
HK1247125A1 (zh) 結晶化合物
ZA201706282B (en) Solid forms of menaquinols
PL3113773T3 (pl) Krystaliczne postaci grapiprantu
PL3532457T3 (pl) Postacie krystaliczne hydroksynorketaminy
IL253479A0 (en) Crystalline forms of efinconazole
IL265445A (en) crystalline forms
GB201419174D0 (en) Crystalline forms
IL270961A (en) Crystalline form of N-butyldeoxygalactonogirimycin
IL269792B (en) Crystalline forms of (s)–apoxolner
HK1255148A1 (zh) 結晶形式
GB201518589D0 (en) Crystalline form of tetraacetylethylenediamine
HUP1500506A2 (en) Salts of palbociclib
IL270937A (en) Crystalline forms of saltalicib
ZA201902553B (en) Crystalline forms